Crohn's Disease
Crohn's disease is a type of inflammatory bowel disease (IBD) that causes inflammation of the digestive tract, leading to symptoms such as abdominal pain, severe diarrhea, fatigue, weight loss, and malnutrition.
Guselkumab for Pediatric Crohn’s Disease
We are studying the safety and effectiveness of guselkumab in children with moderately to severely active Crohn’s disease. This trial aims to see how well the treatment works after initial positive responses.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Do you have a diagnosis of Crohn's Disease or fistulizing Crohn's Disease?
- Is your Crohn's Disease currently moderately to severely active?
- Have you had any bowel surgery in the last 6 months?
- Do you have any complications from Crohn's Disease, like strictures or abscesses?
- Have you had an inadequate response to your current Crohn's Disease treatment?
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Medical University Of Vienna
Department of Pediatric Nephrology and Gastroenterology
Vienna, Austria
UZ Brussel
Pediatric gastroenterology
Ganshoren, Belgium
UZ Leuven
Pediatric gastroenterology
Heverlee, Belgium
Sponsor: Janssen - Cilag International
Last updated: Nov 27, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.